Completed

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

I2V-MC-CXAD - ClinicalTrials.gov - NCT02737072

The main purpose of this study is to evaluate the safety and tolerability of chemokine (C-X-C Motif) receptor 4 (CXCR4) peptide antagonist LY2510924 and durvalumab for phase 1a and 1b in participants with advanced refractory solid tumors.
How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment.
Email
Completed

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

I2V-MC-CXAD - ClinicalTrials.gov - NCT02737072

The main purpose of this study is to evaluate the safety and tolerability of chemokine (C-X-C Motif) receptor 4 (CXCR4) peptide antagonist LY2510924 and durvalumab for phase 1a and 1b in participants with advanced refractory solid tumors.
How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

45

Trial Dates

September 2016 - August 2018

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Solid Tumor

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

45

Trial Dates

September 2016 - August 2018

Trial Phase

1

Not the right fit? Sign up to receive updates on new Solid Tumor trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy

Solid Tumor Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?